Skip to content

Correlation study for expression of peripheral blood Th17/Treg cell axis in HSPN patients

Correlation study for expression of peripheral blood Th17/Treg cell axis in HSPN patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR1900002525
Enrollment
Unknown
Registered
2019-08-14
Start date
2019-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Henoch-Sch?nlein purpura nephritis(HSPN)

Interventions

Healthy control group:N/A

Sponsors

Hubei University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria of study group(HSPN subjects) : 1) Aged 18-60 years; 2) In accordance with diagnostic criteria of HSPN in the Clinical Guidelines-Nephrology Section which was edited by the Chinese medical association in 2011; 3) eGFR >=60 (mL/min / 1.73 m2; the MDRD formula); 4) 24-h UTP <=3.0 g; 5) Willing to provide informed consent and complete the process required by the study. 2.Inclusion criteria of control group (healthy subjects): 1) Aged 18-60 years; 2) Routine items such as blood, urine, feces, liver and kidney functions, and blood lipids are within the normal range in medical examination reports; 3) To provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria of study group(HSPN subjects) : 1) Women during pregnancy or lactation; 2) Participating in interventional clinical trials 3) Patients who have been treated with glucocorticoids and immunosuppressants for the past 3 months or are being treated due to HSPN; 4) I or II type diabetes; 5) NYHA Class III or IV heart failure; 6) Viral hepatitis or cirrhosis; 7) HIV infection or AIDS; 8) Malignant tumors; 9) Have been receiving dialysis for more than 1month, and/or organ or bone marrow transplantation; 10) Have been diagnosed as polycystic kidney and other hereditary kidney diseases. 2.Exclusion criteria of control group(healthy subjects) : 1) Persons who have a history of chronic diseases such as hypertension, diabetes, coronary heart disease, hyperuricemia or hyperlipidemia; 2) Persons who have a history of genetic diseases; 3) Patients with immunological and allergic diseases; 4) Patients with malignant tumors.

Design outcomes

Primary

MeasureTime frame
ROR?t, Foxp3;IL-17, IL-10;Th17, Treg;

Countries

China

Contacts

Public ContactXue Xue

Hubei University of Traditional Chinese Medicine

xue025004138@163.com+86 13971217560

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026